Overviewing Cardiac Safety Profile of Vildagliptin 100mg SR -ft-Prof. Dr Aravinda Jagadeesha - Video
|
Overview
Vildagliptin has established itself over the years by controlling the blood sugar levels in patients with type 2 diabetes mellitus. It is used along with diet and exercise to improve blood sugar control in adults with type 2 diabetes. It also displays significant HbA1c lowering and has a low risk of edema, as well as that of hypoglycemia. These characteristic features make vildagliptin a favorable partner for combination therapy as well as newer formulations like sustained release.
In this video, Prof. Dr Aravinda Jagadeesha, a diabetologist and the chairman at Dr. Aravinds Diabetes Centre in Bengaluru, India talks about how Vildagliptin and how it has proven itself in the past 15 years. In particular, Dr Jagadeesha provides his viewpoints on the cardiac safety profile of Vildagliptin 100mg SR.
In the case of Cardiovascular Safety, Vildagliptin has a plethora of studies including 3 Real-world studies, 3 Meta-analyses, and 1 RCT, establishing safety in over 10 lakh patients. The studies demonstrated that Vildagliptin is not associated with increased Cardiovascular risk, including the risk of Chronic Heart Failure. Even a thorough QT study demonstrated that Vildagliptin has no prolonged QT interval or effect on cardiac conduction even at the highest daily therapeutic dose.
Speakers
Prof. Dr Aravinda Jagadeesha, MBBS, MD (Internal Medicine), is a diabetologist practising in Bengaluru, India. Dr Jagadeesha has also done an MRCP (UK) degree from the Royal College Of Physicians, London University, UK. His interests lie in in-depth knowledge of related areas of specialization like Diabetology, Internal Medicine, Obesity Speciality etc. He is currently the chairman at Dr Aravind's Diabetes Centre in Bengaluru, India.
Dr. Nandita Mohan
BDS, MDS( Pedodontics and Preventive Dentistry)
Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751
